Clinical Trial Update: Naftopidil 75mg for Improving Clearance of Urinary Stones [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating naftopidil 75 mg for improving clearance of urinary stones, including nephrolithiasis and ureterolithiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis
• Ureterolithiasis

Drugs mentioned

• Naftopidil (Naftopidil)

Snippet

Sponsor: Samsung Medical Center | Conditions: Kidney Calculi, Ureter Calculi | Phase 4 | Status: UNKNOWN